Amrinone Lactate

乳酸氨力农

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAmrinone Lactate
Drug Alias Name乳酸氨利酮Inamrinone Lactate乳酸安吡酮Inocor
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaHeart Failure
Original Approved Country/TerritoryUnited States
Original Approved Date1984/07/31
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC01CE01
Related LinksWikipediaDrugBankKEGG